Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan:33 Suppl 27:52-53.
doi: 10.1111/pai.13629.

Update on idiopathic anaphylaxis

Affiliations

Update on idiopathic anaphylaxis

Mauro Calvani. Pediatr Allergy Immunol. 2022 Jan.

Abstract

Idiopathic anaphylaxis (AI) refers to anaphylaxis without a recognizable cause after a comprehensive allergic workup. The diagnostic approach usually includes an accurate clinical history aimed at excluding both the most and the less frequent causes of anaphylaxis and all pathologies that may resemble anaphylaxis. AI is more common in adults than in children. The epidemiology of AI has been reduced in recent years, probably to increase knowledge and discover new clinical entities, such as the α-gal anaphylaxis. Anaphylaxis results from the massive activation of the mast cells (MCs). Thus, it is also necessary to exclude MC disorders, such as mastocytosis and mast cell activation syndrome, and α-tryptasemia, which may manifest with IA symptoms.

Keywords: allergens; idiopathic anaphylaxis; mast cells; mastocytosis.

PubMed Disclaimer

References

REFERENCES

    1. Bilò MB, Martini M, Tontini C, Mohamed OE, Krishna MT. Idiopathic anaphylaxis. Clin Exp Allergy. 2019;49:942-952.
    1. Pattanaik D, Lieberman P, Lieberman J, Pongdee T, Keene AT. The changing face of anaphylaxis in adults and adolescents. Ann Allergy Asthma Immunol. 2018;121:594-597.
    1. Gulen T, Akin C. Idiopathic anaphylaxis: a perplexing diagnostic challenge for allergist. Curr Allergy Asthma Immunol. 2021;21:11.
    1. Fenny N, Grammer LC. Idiopathic anaphylaxis. Immunol Allergy Clin North Am. 2015;35:349-362.
    1. Lange M, Hartmann K, Carter MC, et al. Molecular background, clinical features and management of pediatric mastocytosis: status. Int J Mol Sci. 2021;22:2586.

LinkOut - more resources